A Study of Pasireotide in People With Prolactinoma

NCT06295952 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Prolactin-Producing Pituitary Tumor

Interventions

DRUG: Pasireotide
OTHER: SF-36 and HADS

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]